Skip to content
☰ Menu
Open access · OA via Europe PMC

Research progress in clinical utilization of H2 as a pleiotropic agent

Zhao Q, Li T, Lv R, Li D, Li H.

Frontiers in pharmacology

Chronic inflammation Human
＋ Sign in to save

Abstract

This article in Frontiers in Pharmacology examines research progress regarding the clinical utilization of hydrogen as a pleiotropic agent.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
Canonical
link ↗
Fetched
2026-10-08 MST

Cite this

APA
Q, Z., T, L., R, L., D, L., &amp; H., L. (n.d.). Research progress in clinical utilization of H2 as a pleiotropic agent. <em>Frontiers in pharmacology</em>. https://europepmc.org/article/PMC/PMC13643697
Vancouver
Q Z, T L, R L, D L, H. L. Research progress in clinical utilization of H2 as a pleiotropic agent. Frontiers in pharmacology.
BibTeX
@article{zhaondResear, title = {Research progress in clinical utilization of H2 as a pleiotropic agent}, author = {Zhao Q and Li T and Lv R and Li D and Li H.}, journal = {Frontiers in pharmacology}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings